News | August 27, 2008

Radiation Oncology Site Visits Rose 5 Percent in 2007

August 28, 2008 – Patients made an estimated 24.5 million radiation therapy or related visits to 2,110 U.S. radiation oncology sites in 2007, approximately a 5 percent increase over 23.2 million visits in 2006, reported IMV Medical Information Division in a recent study.

The top three cancer site types include prostate, breast and lung cancer, which account for 21 percent, 20 percent and 13 percent, respectively, of all cancer site types treated using radiation therapy.

“While the number of patients treated with radiation therapy every year is relatively stable, the technological sophistication of radiation oncology departments is continuing to advance. Digital imaging has become integrated into treatment planning and to guide tumor treatment real-time,” observed Lorna Young, senior director, Market Research. “Over half of the radiation oncology sites provide treatments using image-guided radiotherapy (IGRT), up from 15 percent of the sites in 2004, using either a dedicated IGRT imaging device or electronic portal imaging. Ultrasound, X-ray and CT are the primary imaging modalities used in IGRT.”

The report also found that nearly all (97 percent) of the radiation therapy treatment plans use CT images, 11 percent use MRI and 11 percent use PET images; and CT simulators comprised over 90 percent of the simulators installed in 2007.

The study also reported that intensity-modulated radiotherapy (IMRT) has been adopted by 87 percent of the radiation oncology sites. Plus, sites having budgets of $1.5 million have increased from 15 percent of 2003 capital budgets to 32 percent of 2008 budgets.

The data source for this report is IMV’s 2006/07 Radiation Oncology Census Database, which provides profiles of radiation oncology sites in the U.S.

Source: IMV Medical Information Division

For more information: www.imvinfo.com

Related Content

California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Philips Unveils IntelliSpace Radiation Oncology at ESTRO 2019
News | Oncology Information Management Systems (OIMS) | April 25, 2019
Philips announced IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity,...
Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...